Back to search

University of Crete (UOC)

Ο ρόλος της έκφρασης των κυκλοφορούντων microRNAs στη διάγνωση των ασθενών με καλώς διαφοροποιημένο Ca θυρεοειδούς. Συσχετισμός με την αποτελεσματικότητα της θεραπείας με ραδιενεργό I-131

Abstract

dc:description

Papillary thyroid carcinoma (PTC) is the most common histological type of thyroid cancer. Despite the generally favorable prognosis of most patients, the identification of reliable, minimally invasive biomarkers remains an important research objective. MicroRNAs (miRNAs) are small non-coding RNA molecules involved in post-transcriptional regulation of gene expression. Their stability in biological fluids and accessibility in serum have generated considerable interest in their potential application as biomarkers for thyroid cancer. The aim of this study was to investigate the expression profile of circulating serum miRNAs in patients with PTC compared with patients with benign thyroid disease and to explore their potential relevance as non-invasive molecular biomarkers.Preoperative serum samples were collected from 14 patients undergoing thyroidectomy, including eight patients with PTC and six patients with benign thyroid disease. The expression levels of 84 malignancy-associated human miRNAs were assessed using a targeted miRNA expression profiling panel. Of the 84 miRNAs analyzed, 65 showed numerically lower expression and 19 showed numerically higher expression in the PTC group compared with the control group. Ten miRNAs exhibited expression changes exceeding twofold, including three upregulated miRNAs (hsa-miR-150-5p, hsa-miR-21-5p, and hsa-miR-23a-3p) and seven downregulated miRNAs (hsa-miR-17-5p, hsa-miR-17-3p, hsa-miR-200c-3p, hsa-miR-296-5p, hsa-miR-574-3p, hsa-miR-885-5p, and hsa-miR-130-3p). Among these, hsa-miR-574-3p was the only miRNA showing a statistically significant difference, with lower serum expression in patients with PTC than in controls (p = 0.0327). Hsa-miR-23a-3p showed increased expression, whereas hsa-miR-17-3p showed decreased expression; however, neither difference reached the conventional threshold for statistical significance.This pilot study identified differences in circulating serum miRNA expression between patients with PTC and those with benign thyroid disease. The downregulation of hsa-miR-574-3p was the principal statistically significant finding, while the expression changes observed for hsa-miR-23a-3p and hsa-miR-17-3p require further investigation. These preliminary results support continued research into circulating miRNAs as potential non-invasive biomarkers for PTC. Validation in larger, independent patient cohorts, together with assessment of diagnostic performance and associations with clinicopathological characteristics, is necessary before their clinical utility can be established.

Degree

thesis:*
Grantor dc:publisher
University of Crete (UOC)
Year dc:date
2026

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Bourogianni, Olga
  • Μπουρογιάννη, Όλγα

Subjects

dc:subject × 13

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/63050

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-20
Source record
OAI-PMH GetRecord
citation

Bourogianni, Olga; Μπουρογιάννη, Όλγα. Ο ρόλος της έκφρασης των κυκλοφορούντων microRNAs στη διάγνωση των ασθενών με καλώς διαφοροποιημένο Ca θυρεοειδούς. Συσχετισμός με την αποτελεσματικότητα της θεραπείας με ραδιενεργό I-131. University of Crete (UOC), 2026. http://hdl.handle.net/10442/hedi/63050